Claribel Pharmaceuticals Private Limited
About Claribel Pharmaceuticals Private Limited
Data last updated:
Claribel Pharmaceuticals Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 05 November 2014 and has been in existence for over 12 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U33111TG2014PTC096243. Its GSTIN is 36AAFCC8263K1ZA (Telangana).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Apsingiker Sravan Kumar and Shaik Mustafa.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 2 – 1 – 290/2 Nagole, Hyderabad, Telangana, India – 500068.
As per the financials filed for FY 2025, the company reported a revenue of ₹88.92 Lakh, a growth of 29% compared to the previous year. For the same year it recorded a net profit of ₹1.18 Lakh (net margin 1.3%) and EBITDA of ₹1.91 Lakh (EBITDA margin 2.2%). Revenue has grown at a compounded annual rate (CAGR) of 27% over three years and 10% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Claribel Pharmaceuticals Private Limited's registered office is in Hyderabad, Telangana. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address2 – 1 – 290/2 Nagole, Hyderabad, Telangana, India – 500068
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Claribel Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Claribel Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Claribel Pharmaceuticals Private Limited, buy the company report.
Financials of Claribel Pharmaceuticals Private Limited
FY 2025 filings availableClaribel Pharmaceuticals Private Limited reported revenue of ₹88.92 Lakh (up 29% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 10% over five years, including 29% growth in the latest year. EBITDA rose 23% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.91 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.18 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.2% | ||||
| Net Profit Margin | 1.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Claribel Pharmaceuticals Private Limited, buy the company report.
Board of directors of Claribel Pharmaceuticals Private Limited
Claribel Pharmaceuticals has 5 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Apsingiker Sravan Kumar | Director | 05 Nov 2014 | 11 Years 11 Months | Current |
| Shaik Mustafa | Director | 05 Nov 2014 | 11 Years 11 Months | Current |
| Katta Bharath Kumar | Director | 05 Nov 2014 | 11 Years 11 Months | Current |
| Gandwaid Ravinder Rao | Director | 05 Nov 2014 | 11 Years 11 Months | Current |
| Ashok Manda | Director | 05 Nov 2014 | 11 Years 11 Months | Current |
Peer comparison
Claribel Pharmaceuticals Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Stride Health Care Private Limited | ₹89.23 Lakh (FY 2024) | -13.0% | Chandigarh, India | |||
| Neovita Biopharmaceutical Private Limited | ₹89.05 Lakh (FY 2025) | 87.0% | Porvorim, Goa, India | |||
| Claribel Pharmaceuticals Private Limitedthis company | ₹88.92 Lakh (FY 2025) | ₹1.18 Lakh | 1.3% | 29.0% | Hyderabad, Telangana, India | |
| Cell Cross Pharmaceuticals Private Limited | ₹88.89 Lakh (FY 2025) | 54.0% | Kangra, Himachal Pradesh, India | |||
| GDF Pharmaceuticals Private Limited | ₹88.68 Lakh (FY 2025) | 11.0% | Gorakhpur, Uttar Pradesh, India | |||
| Qrit Life Sciences Private Limited | ₹88.64 Lakh (FY 2021) | 119.0% | Bangalore, Karnataka, India |
To see the full peer comparison of Claribel Pharmaceuticals Private Limited, buy the company report.
Auditor
Claribel Pharmaceuticals Private Limited is audited by C V S BALACHANDRA RAO & CO for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| C V S BALACHANDRA RAO & CO | FY 2023 | 007507S |
Shareholding
The shareholding of Claribel Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Claribel Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Claribel Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Claribel Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Claribel Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAFCC8263K1ZA | Telangana | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Claribel Pharmaceuticals Private Limited, buy the company report.
Recent activity
Claribel Pharmaceuticals Private Limited has 6 board changes on record since 2014: 5 appointments and 1 cessation. The latest: Madishetty Venkata Ramana ceased to be Director on 15 Apr 2019.
Frequently asked questions
Claribel Pharmaceuticals is an active private limited company based in Hyderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 05 November 2014 (12+ years old) and is registered under CIN U33111TG2014PTC096243.
Claribel Pharmaceuticals has 5 current directors:
- Apsingiker Sravan Kumar - Director
- Shaik Mustafa - Director
- Katta Bharath Kumar - Director
- Gandwaid Ravinder Rao - Director
- Ashok Manda - Director
The latest financial statements of Claribel Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Claribel Pharmaceuticals is 36AAFCC8263K1ZA, registered in Telangana.
The CIN (Corporate Identification Number) of Claribel Pharmaceuticals is U33111TG2014PTC096243. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Claribel Pharmaceuticals was incorporated on 05 November 2014, making it 12+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Claribel Pharmaceuticals by revenue are Stride Health Care Private Limited, Neovita Biopharmaceutical Private Limited, Cell Cross Pharmaceuticals Private Limited, GDF Pharmaceuticals Private Limited, Qrit Life Sciences Private Limited, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (wholesale trading).
Madishetty Venkata Ramana ceased to be Director on 15 Apr 2019. Apsingiker Sravan Kumar was appointed as Director on 05 Nov 2014. Ashok Manda was appointed as Director on 05 Nov 2014. Claribel Pharmaceuticals has 6 board changes on record in total.
The registered office of Claribel Pharmaceuticals is at 2 – 1 – 2902 Nagole, Hyderabad, Telangana, India – 500068.
Claribel Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.
The compliance status of Claribel Pharmaceuticals is compliant as of 25 September 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
